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Résumé français
L’hypertension essentielle constitue un facteur de risque important pour les
maladies cardiovasculaires et affecte aussi un grand pourcentage de la population
humaine. La pression artérielle (PA) chez les animaux est influencée à la fois par
des facteurs génétiques et environnementaux. L’hypertension est définie en
génétique comme étant un trait quantitatif et multifactoriel sous contrôle
polygénique. Nos études antérieures par analyse de liaison ont suggéré la présence
d’un locus pour trait quantitatif (QTL) associé à la pression artérielle sur le
chromosome 2. Notre objectif était de vérifier ces résultats à l’aide de modèles
animaux congéniques.
Afin d’étudier l’hypertension dans un environnement homogène, nous
utilisons des souches de rats co-sanguines, où tous les animaux sont génétiquement
identiques. Des lignées congéniques sont construites par une série de croisements
entre le rat S (Dahl sait-sensitive hypertendu) et le rat L (rat Lewis nonriotendu).
Ceci résulte en une souche congénique dont le génome piovient de la souche
hypertendue S, sauf pour une région qui est remplacée par la région homologue de
la souche nonnotendue Lewis. Ces lignées permettent ainsi d’associer un
changement potentiel de la PA sur le chromosome 2 lorsque comparée à la lignée
S.
Nous avons obtenu des résultats pour 4 souches congéniques. Deux de ces
quatre souches ont montré la même pression art &ielle moyenne (MAP) que le rat
S. Donc, elles ne sont pas significativement différentes par rapport à S. La souche
congénique C2S.L1 pourrait être classifiée comme une souche « hyper »
hypertendue de S dû au fait que sa préssion artérielle était plus élevée que celle de
S même si elle contient des allèles provenant de la souche normotendu Lewis. Les
pressions artérielles systoliques et diastoliques varient de façon concordante avec
les valeurs de MAP.
Donc, le chromosome 2 du rat Dahl contient un QTL pour la pression
artérielle. La découverte de gènes pour ce QTL sur le chromosome 2 peut nous
donner une idée des mécanismes qui contrôlent la pathogenèse de l’hypertension.
Mots clefs
Hypertension essentielle, pression artérielle, souche congénique, chromosome 2, rat
DahI sait-sensitive, modèle animal rat
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Résumé anglais
Essential hypertension is an important risk factor for many cardiovascular
diseases and affects a large percentage of the hurnan population. Biood pressure
(BP) in animais is influenced at the sarne tirne by enviromnental and genetic
factors. In the study of genetics, hypertension is defined as being a muitifactorial
quantitative trait under polygenic control. Our previous studies using linkage
analysis have suggested the presence of a quantitative trait locus (QTL) associated
to blood pressure on chromome 2. Our objective was to verify these resuits using
congenic animal models.
In order to study hypertension in a hornogeneous environrnent, we used
inbred rat strains where ail animais are genetically identical. Congenic strains were
obtained by crossing the S rat (Dahi sait-sensitive hypertensive) and the L rat
(Lewis nonnotensive rat). They are crossed until we obtained a genetic background
ofthe S rat and the portion containing the QTL replaced by the homologous portion
of the L rat. These strains will therefore permit to associate a potential change in
arteriai pressure on chromosome 2 when compared to the S strain.
We obtained resuits for four congenic strains. Two of the four strains
demonstrated the same mean arterial pressure (MAP) as the S rat. Therefore, they
are flot significantly different to S. The C2S.Li strain could be classified as a
hyper-hypertensive strain of S due to the fact that its MAP was higlier than that of
the S strain even thought it contains alleles from the Lewis rat. The diastolic and
systolic artenal pressures varied in the same manner as the MAP.
In conclusion, the Dahi rat chromosomes 2 contains a QTL for blood
pressure. The discovery of genes for this QTL on rat chromosome 2 could help us
to better understand the genetics of hypertension.
Key words
Essential hypertension, blood pressure, congenic strain, chromosome 2, Dahi sait
sensitive rat, rat animal model
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1Introduction
Chapter 1
The concept of hypertension
1.1 lligh Blood Pressure
Hypertension is a disease that causes organ damage throughout the body due to
high blood pressure that is present flot only dunng physical activity but also at rest. The
terrn “high blood pressure” adequately describes a temporary condition caused by stress
and physical activity, whereas “hypertension” is a more suitable tenu for a persistent
disease state(1). Diagnosis of essential hypertension includes exclusion of secondary
hypertension such as that associated with endocnnological disease, renal disease and
renovascular disease (2). A few monogenic diseases (inheritance hypertension) have been
defined as unusual hypertension.
Although evidence strongly suggests that essential hypertension is a multifactorial
inheritance disease (3), a clear causal gene of essential hypertension has flot yet been
identified. There are rnany environrnental factors that affect essential hypertension
including obesity, diabetes, drinking and smoking. Accounting for these effects is one of
the issues that complicate isolation of susceptibility genes.
Blood pressure is the hydrostatic force that the blood exerts against the vessel
walls, thus creating a cardiac cycle. Each cardiac cycle is cornprised of two altemate
phases, the diastolic and the systolic phase. During the systolic phase, the cardiac muscle
contracts which in tum creates a propulsion of blood from the cavities of the heart. This
in tum supplies the organs of the body with the proper nutrients and essential oxygen.
With every contraction of the heart, 70 ml ofblood is propelled into the arterial systemic
system; this is called the systolic volume. During the diastolic phase, the ventricles fil
with blood which is ready to be pumped throughout the body once again. Both the
systolic and the diastolic phases have an approximate duration of 0.4 seconds each and
induce a pulse of about 65 to 80 beats per minute.
3Blood pressure is greater in arteries than in veins and reaches a peak in the
arteries during the systolic phase while the heart is contracting; this is called the arterial
systolic pressure. Variations ofblood pressure depend on cardiac output and the degree of
peripheral resistance to the flow of out coming blood. If the volume ofblood is increased
and the vascular resistance is also increased this in tum augments the pressure.
In medical terms, blood pressure is rneasured in two parts: systolic and diastolic.
The systolic pressure corresponds to the pressure exerted by the blood on the walls right
after the passing of blood. A resuit of typical biood pressure would be presented as such
systolic pressure! diastolic pressure, using as unit millimeters of mercury (mmllg).
Optimal pressure being situated around 1 20!80 mmHg.
The kidneys play a key role if not essential role in the control of blood pressure.
There 11es a crucial balance between sait intake and peripherai resistance. for example, if
the arnount of sait intake increases it will be followed by an increase of the extracellular
volume and plasmatic volume. This increase in volumes results in escalation of the blood
pressure which in tum increases the systolic volume. In the long run, the final effect of
the auto regulating systems is increase of the peripheral resistance which brings the
systolic volume back to homeostasis. The augmentation of the peripheral resistance
could be substantial, this couid lead to hypertension. Nonual kidneys would minimize
these rises in the extracellular fluid and the systolic volume, therefore minirnizing the
elevations in blood pressure.
In the arteriai waiis ofthe body, we also find smooth muscles. The contractions of
these srnooth muscles contract the arterioles which in tum increase the resistance and
consequentiy increase the artenal pressure. Once the srnooth muscles release their
pressure, the arterioles dilate and the arterial pressure drops. The muscles in the arterioles
obey the signais given to them by nerves, hormones and other messengers.
4Physical or ernotional stress can also elevate blood pressure by causing nerve end
hormonal reactions which will compress the blood vessels. Many other mechanisrns also
control blood pressure. Baroreceptors which are situated in the blood vessels detect large
changes in blood pressure and send the information to the brain to be processed. The
factors produced by the blood vessels influence the arterial rigidity and cause
vasodiÏation or a vasoconstriction. Furtherrnore, atrial natriuretic peptides produced by the
brain and the heart, in response to an elevation in pressure in these organs also oppose the
vasoconstrictive effect of angiotensin and endothelin and the reabsorption of sodium
which is started by the rennin-angiotensin system. These peptides also influence the re
absorption of sodium which is induced by the renal angiotensin system (4).
1.1.1 Renin-angiotensin aldosterone system (RAA)
The RAA (figurel) is vital to the preservation ofarterial pressure, horneostasis of
the vascular volume and the balance of electrolytes, specifically during the loss of fluids
or a drop in pressure. Renin was first isolated in 1898 from rabbit kidneys and was
described as a substance that influenced blood pressure (5). This enzyme is released in
the circulation by the kidney under the control of multiple signais and acts on
angiotensinogen in the liver. Once angiotensinogen is cleaved by the renin protease,
angiotensinogen I (Ang 1) is created. Ang lis then converted to angiotensin II (Ang II) by
the angiotensin conversion enzyme (ACE). Ang II is the principal vasoactive honnone of
the RAA system. Its effects include vasoconstriction, the stimulation of aldosterone
secretion and the re-absorption of sodium by the kidney. The RAA system acts in the
circulation but also exists in many tissues and organs.
The action of Ang II is effective via it’s linking to specific receptors (AT1 and
AT2). These receptors are part of a family of receptors coupled to Gi proteins and are
expressed in rnany tissues but primarily in the brain, kidney, and the suprarenal glands.
Two sub-types ofthe ATI, AT1a and AT1!3 receptors were identified in rodents (6).
5These two receptors are the product of two genes (Agtrl a and Agtrl F3) and are
differentÏy expressed and reguÏated. Il was demonstrated that the Alla receptor was
rnostly implicated in the regulation of the peripheral vascular rigidity and the response to
increased pressure in the central nervous system (SNC). The Ail f3 receptor is required
for the agonistic response ofAngil in the SNC (7).
The RAA system works along with other systems to monitor and maintain pressure
and fluïds. One such system is the sympathetic nervous system. It constitutes a balance
to the vasodilation systems. In the majonty of patients which suffer from essential
hypertension, tEe arterial pressure drops when treated with ACE inhibitors or antagonists
of the Angli receptor. There is also a drop in arterial pressure with certain treatments that
activate the RAA system. Therefore one can understand that although it’s clear that the
RAA system does play a primordial role in controlling blood pressure, it does not
constitute the prirnary cause of hypertension nor is it the only deterrninant of blood
pressure in essential hypertension (8).
Ail systems controlling or regulating blood pressure act together in a complex
fashion. TEe role of these systems bas been established in short terrn homeostatic
responses. It’s difficuit to examine whether these pathways contribute to blood pressure
detennination in the long terni Blood pressure must be measured in intact living
organisms where ail these systems interact in a complex manner, thus making it very
difficuit to distinguish pnrnary alterations versus adaptive secondary responses.
6Plasmic
Angiotensinogen
Cardiovascular
Control by
Arterioles Meditila
t J L
Plasmic
I ANGII
l% J
ACE r plasmic
Figure 1. The renin angiotensin system (RAA)
This figure is a schematic representation of the control of arterial pressure on various components. This
figure is based on a figure taken from Human Physiology figure 20-13 (5).
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71.2 Hypertension
Hypertension (elevated blood pressure levels exceeding H0/90 rnmHg according
to WHO criteria) is a common complex disorder which affects 15-20% of adult
population in Western societies (8). It is classified as primary (essential) or secondary
hypertension. The former type is used to describe hypertension without a known
pathology. The diagnosis of essential hypertension is made when no other cause for
increased blood pressure is found. This form of disease contnbutes about 90-95% of ail
hypertension cases. Whereas in 5% of cases, the cause of hypertension is known to be
secondary to conditions such as pheochromocytoma, prirnary hyperaldosteronism
(Conn’s syndrome), Cushing’s syndrome (excessive g1ucocorticoids), renal disease or
drug induced. This disease is considered to be a multifactorial disorder with many
genetic, environmental and dernographic factors contributing to blood pressure variation.
The complex nature of the involved mechanisrns makcs it difficuit to identify a single
pathological system of prime importance in regulating blood pressure.
Hypertension is one ofthe rnost important risk factors for cardiovascular diseases.
It is one of the principal independent nsk factors for stroke, myocardial infarction, and
end-stage renal disease. Furthermore, it is associated with rnany other complications that
affect vital body functions such as left ventricular hypertrophy, diastolic dysfunction,
congestive heart failure, cerebral thrombosis, encephalopathy and retinopathy (9).
$1.2.1 Epidemiology
As mentioned previously hypertension is a discase which is very present in our
society. It affects about 50% ofthe population aged 65 and over (10). Also, a 55 year-old
with normal blood pressure has a 90% chance of developing hypertension during his or
her lifetime. According to the NHANES (Third National Health and Nutrition
Examination Survey) only 53.6% of peopic suffering from hypertension are treated.
Surprisingly, only 27.4% of those treated are treated successfully (blood pressure under
140/9OmrnHg). R is also clear from farnily and epidemiological studies that hypertension
arises from a complex interplay between genetic and environrnental lifestyle exposures
including dietary sodium intake, excess alcohol consumption and body weight (10).
1.2.2 Monogenic Hypertension (Mendelian)
Monogenic hypertension is responsible for approximately 5% of hypertension
cases and is considered as a unique trait because it dernonstrates mendelian transmission.
A single defective gene is responsible of the disease and its great variations in blood
pressure. A lot of information obtained in the fielU of hypertension came from single
gene disorders from which gene variants causing the trait were characterized (11).
Liddle’s syndrome
Liddle’s syndrome is an autosomal dominant disorder that leads to increased re
absorption of sodium and water in the renal collecting tubules and hence leads to
hypertension. The syndrome was found to be due to mutations in the genes coding for the
3 and ‘ subunits of ENaC (epithelial sodium channel).
9Syndrome of apparent mineralocorticoid excess (AME)
AME is an autosomal recessive disorder charactenzed by an early onset of moderate to
severe hypertension. Patients with AME1 have a deficit in 1 1 3-hydroxylase in their
systern(12). As a resuit, 11 3-hydroxylase is under the control of the adrenocorticotropic
hormone which wiii be secreted and lead to an increase in sait and water re-absorption as
well as a risc in biood pressure.
Mineraiocorticoid receptor (MR) activating mutation
Substitution of leucine for senne at codon 810 (S81 OL) in the mineralocorticoid receptor
causes early onset hypertension that is markedly exacerbated in pregnancy. This mutation
resuits in constitutive MR activity and aiters receptor specificity. Ail steroids, including
progesterone, that dispiay antagonists properties when bound to the wild type MR are
able to activate the mutant receptor (L8 10).
Pseudohypoaldosteronism type II
Pseudohypoaldosteonism type II is an autosomal dominant disease characterized by
severe hypertension, hyperaikernia and sensitivity to thiazide diuretics (12). This resuits
from altering Na+C1- and K+ handiing. Mutations in two members of the WNK kinase
family, WNK 1 and WNK 4, cause the disease. Both genes are highiy expressed in the
kidney.
10
Names Mutations Hereditary Form
Liddle’s syndrome j3 ENaC Autosomal Dominant
y ENaC
AME 1 1 f3-hydroxyiase Autosomal Dominant
MR activating mutation S$1OL Autosomal Dominant
PHAII WNK 1 Autosomal Dominant
WNK4
Table I- Monogenic forms of hypertension
Examples of monogenic forms of hypertension
Descriptions of diseases and table based on Tanira et al (2004) and Liflon et al (200])
The above mentioned forms of hypertension affect a common pathway via the
control of sait reguiation and sait re-absorption in the iddney, which indicates a key role
of the kidney in the pathophysiology of hypertension. Extensive data from experimental
animais suggest that hypertension cannot be sustained without active participation of the
kidney (13). In addition, marked elevation of biood pressure in response to increased
dietary sait intake has been observed in humans, primates and rodents (14), indicating the
importance of inherited variation in renal sait handiing. The relation between genetic
variation and monogenic forms of hypertension provides insight into the more common
forms of hypertension, especiaily in patients where the genetic defect has been
characterized.
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1.2.3 Essential Hypertension
Essential hypertension constitutes the vast rnajority of hypertension cases. It is a
multifactorial forrn of the disease that implicates such determinants as genetics and
environrnent. Risk of hypertension tends to concentrate itself in farnilies and a strong
aggregation ofhigh blood pressure is observed in rnost ofthese farnilies. Given the fact
that the sarne family flot only shares environment but their genes, it makes it very
difficuit to separate these two influences. Moreover, blood pressure is a complex trait and
the clinical phenotype of high blood pressure can be observed in a variety of
pathophysiological rnechanisms.
It is now widely accepted that this type of hypertension is polygenic, this means
that it is caused by a complex interaction between rnany genes. Essential hypertension
would therefore be detenriined by the interaction of a few major genes or many minor
genes. Depending on the combination ofgenes, different interactions would modulate the
deterrnination ofblood pressure and the genetics would influence these interactions.
Most of the traits that have a significant impact on the health of a population
implicate many genes which interact amongst themselves. Most of the time these genes
are also influenced by environmental factors.(Figure 2) Very rarely do forrns of this
disease implicate only one gene. Very ofien, forrns of this disease undergo a very
rigorous regulation by a multitude ofgenes. Furtherrnore, this regulation could vary from
one individual to the other, depending on the variety inherited. This renders the task of
identifying the exact causes of essential hypertension much more difficuit.
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Figure 2- Gene-environment interaction
Figure representing the interactions ofthe many factors influencïng hypertension.
1.3 Hypertension and Environment
Many genetic and environmental factors affect hypertension. Examples of such
factors would be: sex, age, race, diet, consumption of alcohol or tobacco etc. The
individual effect of genes can be additive or more complex and epistatic. As mentioned
previously, the gene-gene interactions and gene-environment interactions, including the
relation between these two groups render the study of this trait very complex.
It has been estimated that the genetic factor contributes from 30 to 50% of the
variation of blood pressure which is observed. The identification of the genes that affect
hypertension lead to a better comprehension of the pathophysiology of this disease. This
information could then be useful to identify the individuals susceptible to this disease
before the physiological manifestation, thus creating a preventive therapy. The
knowledge of the genetic basis of this disease will also provide a better treatment by
prescribing medication that responds to the specific needs of the affected individual.
13
1.3.1 Hypertension in industrialized populations
Many studies have shown a correlation between blood pressure and the location
of inhabitance. Individuals that live in industrialized areas have blood pressure that
increases which age. On the contrary, individuals living in non-industrialized areas, have
ablood pressure which rernains constant (15).
Stress is another environrnental factor in industrialized populations which is
important in the development of hypertension. It lias been demonstrated that hypertensive
or pre-hypertensive subjects, with a family history of positive hypertension, have a
greater increase in blood pressure when they are exposed to a physical or mental stress
than subjects which are of normotensive progeny witli the same basal levels of blood
pressure (16). A prolonged exposure to a chronic elevated stress throughout a long
period of time could cause an anatornical adaptation in the heart and vessels and would
therefore contribute to maintain a high blood pressure (16).
Many response genes could also be implicated in the environmental susceptibility
to hypertension. Two such genes in the rat are hsp7O and tnfa. Temperature and
immobilization of the animal have been associated to changes in blood pressure and
expression ofthese genes (17).
1.3.1 Hypertension and obesity
The association between hypertension and obesity lias been well documented. It
lias been demonstrated that bÏood pressure is closely linked to body mass(17). This
relation is valid for various populations and is confirmed flot only in chuidren but
teenagers and adults as well. Studies have shown that nearly haif of the population which
is considered rnedically obese is hypertensive (18). Obesity brings upon physiological
changes such as an augmentation in the resistance of the blood vessels and a cardiac
hypertrophy (18). It lias also been observed that a reduction of intra-abdominal fat is
linked to a decrease in blood pressure in patients which are hypertensive and obese.
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1.3.2 Consumption of aicohol and hypertension
Therc exists a correlation between alcohol and a high arterial pressure. Even
today, there is no known signaling pathway which couid clearly explain this iink. In the
Caucasian population, men have a diastolic and systolic pressure that increases with the
arnount of aicohol consumed. This tendency is also observed in women but the increase
in arterial pressure is iess pronounced (19). In the African-Arnerican populations, the
men had a constant increase of diastolic as well as systolic pressure for the same alcohol
consumption.
1.4 Sait sensitivity and hypertension
The amount of sait in one’s diet is an important environmentai factor in the
regulation of biood pressure (20). It lias been observed that the prevalence of
hypertension is low in certain primitive societies with a diet which is feeble in sait (21).
In the 1940’s, it was dernonstrated that a iow-salt diet could reduce biood pressure in
patients suffering from severe hypertension. Aiso, in certain patients (20 to 40%), a iow
sait diet could heip them to better control biood pressure (21).
Normotensive and hypertensive subjects can be either sensitive or resistant to the
effects of an increase in blood pressure which is due to sait. Meaning that their blood can
be sensitive or flot to the effect of sait intake. In hypertensive subjects, those that werc
sait-sensitive had an elevation in biood pressure during a period of 24 hours, whereas the
subjects which were sait-resistant had a high biood pressure only during their sleeping
period. The kidneys have been long suspected of playing a central role in sait sensitivity
and arterial pressure. It lias aiso been dernonstrated that sait sensitivity couid also be
rnodified by the presence ofother ions in the diet.
15
1.4.1 Importance of ion transportation
At the base, essential hypertension is created by an imbalance between the
peripheral resistance of the biood vessels and the blood volume. The mechanisms which
are responsible are the regulatory contraction ceils of the smooth vascular muscle in the
arteries which forrns the resistance and the regulation of extracellular fluids. It has been
dernonstrated that the response of the srnooth muscle celis would play a role in the
regulation ofblood pressure (22).
The peripheral resistance and the regulation of the extracellular volume can be
linked to the membrane which separates the extracellular and intracellular spaces. The
structure and function of this membrane plays a key role in the pathogenesis of
hypertension. The plasmic membrane is a dynamic structure that maintains its
interactions with adjacent cells with the help of specific signais from the entire organism
1.4.2 Role of sodium
There exists a relation between the consumption of sodium and the development
of hypertension in certain animal models and patients suffering from salt-sensitive
hypertension. Cellular sodium is increased in rnany types of cells (erythrocytes,
lymphocytes) in essential hypertension. This is due either to an increase or decrease in
the entry of sodium. The principal deterniinant of this unequal distribution of sodium
between the intracellular and extracellular compartments is the ATPase NA+K+ pump
which exports three sodium ions for two potassium ions irnported into the ceil. This
maintains a low concentration of intracellular sodium and a high concentration of
potassium. This unequal distribution is responsible for the inflow of other ions between
cornpartments. It is also possible that this pump is barred in certain forrns of hypertension
which are characterized by a large quantity of sodium and water.
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1.4.3 Role of intracellular calcium
Intracellular calcium is a major determinant in the contraction of the srnooth
vascular muscle. It is also a key elernent in the cellular response to agonists, intracellular
calcium acts a second messenger. In resting celis, it is kept constant by a variety of
rnechanisms which are rnediated by sodium pumps located in the intracellular organelles.
In hurnans and experirnental models affected by hypertension, calcium homeostasis is
affected.
The essential components of calcium homeostasis are the plasmic calcium
ATPase, which pumps the calcium out of the celI and the sodium-calcium exchanger
(NCX) which pushes the calcium out against its gradient in exchange with sodium which
is pumped with its gradient. An equilibrium between these two rnechanisms maintains an
intracellular concentration of calcium which is four tirnes weaker than the extracellular
concentration. It has been demonstrated that entry of calcium via the type 1 NCX
exchanger (NCX1) is implicated in the contractile regulation ofthe small arteries as well
as in the development of sait-dependent hypertension. (21)
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Chapter 2
Genetic approach
It’s clear at the present time that essential hypertension is a polygenic and
hereditary disease. Studying the genetic bases of hypertension is a very difficuit task due
to the fact that there are many genes involved each having a partial effect on blood
pressure. The hurnan population is genetically heterogeneous, each individual possesses a
particular version of each of his or her genes and the combination of these genes renders
each person unique. This phenomenon complicates the research of the responsible genes
for this complex trait. Given the fact that each individual possesses slight variation
differences for each gene, it is difficuit to discover a srnall difference in the genome of a
varied human population.
The main strategy used to study the genes irnplicated in hypertension is the
identification of QTLs (quantitative trait loci) which are responsible for the variations of
arterial pressure observed. The genes which contribute to a complex quantitative trait are
known as QTL (23), the quantitative trait of hypertension being arterial pressure. The
units used to measure arterial pressure are rnmHg also known as millimeters ofmercury.
Due to the fact that a QTL is responsible for only a fraction of the trait observed, the
phenotype-genotype colTelation is weak (24).
An epistatic interaction happens when the combined effect of two or more genes
cannot be predicted by a simple addition of their cffccts (25).An example of an additive
effect would be on Chr. 10 in the Lcwis rat where 3 QTLs were found to interact
additively. (59) The influence of epistatic genes on complex traits is not very well
understood due to the complexity of the studied traits. A more precise definition for an
epistatic interaction was given by Bateson: an epistatic interaction happens when a gene
interferes with the phenotype of another gene which is situated on another allele. In
short, the phenotype is detennined by the first gene and not the second.
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There are only a small number of epistatic interaction cases in the study of
complex traits such as QTLs. This is due to the analysis tools which are used. The
majority of these tools calculate the general effect of the QTL on the phenotype and not
the interaction effect ofrnany QTLs (26).
Even with the difficulties encountered in epistatic interactions, there do exist
some examples. Ohno et al. dernonstrated the presence of epistatic interactions between
hypertension and the SrcalI (sarco (endo) plasmic reticulum Ca2+-dependant ATPase II)
(27). Rapp’s team also dernonstrated the possibility of an epistatic interaction between
two arterial pressure QTLs in the rat (2$). They located a QTL on both chromosome 2
and chromosome 10. Using genetic linkage studies, they observed a weak segregation of
the F2 population between the QTLs of chromosome 2 and chromosome 10. To prove the
presence of an interaction between these two QTL5, they constructed a double congenic.
A double congenic is a congenic strain were two regions are targeted: the genomic
background being from one strain, and the QTL region of chromosome 2 and 10 have the
genotype of another strain. Thc QTL of chromosome 2 increased arterial pressure versus
the parental hypertensive strain. Logically, one would think that the combination of these
two QTLs in the same congenic strain would have an amplifying effect on the arterial
pressure. In other words, the QTL of chromosome 2 increases the arterial pressure by 8
mmHg, the QTL of chromosome 10 increases arterial pressure by 1 5mmHg, if the
interaction of these two QTLs is additive we expect to observe an increase of23mmHg of
the arterial pressure. Surprisingly, an augmentation of 47 mmHg was observed (29). This
demonstrates that the —BP (blood pressure lowering) QTL is epistatic to the +BP (blood
pressure raising) QTL.
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Figure 3- Epistatic effect of Chr.2 BP QTL and Chr 10 BP QTL
Representation of arterial pressures and observed effect as published in Rapp et aÏ. (28)
Advancement in the domains of molecular biology and genomic techniques, in
combination with those of physiology has given birth to functional genomics. functional
genomics is defined as a multidisciplinary approach in the study of genes, their products
and interactions (30). Other strategies have also been put into place to identify the genes
which are susceptible to hypertension (31).
Such strategies are:
1. Candidate gene approach
2. Linkage analysis
3. Comparative genomics
3. Animal models
4
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2.1 Candidate gene approach
Most genetic studies implying hypertension-predisposïng genetic loci have used
this strategy to study candidate genes. This systernatic approach assumes that a gene or a
set of genes involving a specific physiological or ceilular function contribute to blood
pressure variation.
Ernploying this approach, sorne candidate genes have been elucidated from the
study of rare monogenic forms of hypertension (Liddle’s syndrome). For essential
hypertension however, at least 51 genes/loci that affect different physiological or
biochernical systems have been describe (32). Most of these studies utilizing genetic
linkage and association rnethods enrolled unrelated individuals in case-control designs.
Although case-control design is useful in hornogeneous populations, thcse studies were
perforrned in heterogeneous populations and thus may have higher probability of errors
due to differences in the studied population (33). Case-control design also renders
candidate gene studies difficuit to be reproduced and less likely to include ail causative
genes and polymorphisms.
The candidate gene approach is limited by our knowledge of the pathophysiology
of the disease in question; we are limited by the known genes that contnbute an effect on
thc complex trait. This approach does not permit us to identify new genes implicatcd in
the pathogenesis of the studied disease.
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2.2 Linkage analysis studies
This method gives estimates for the genetic pararneters behind any trait(s) being
studied and proposes a mode! to explain the inheritance pattern of phenotypes and
genotypes observed in a pedigree. It provides information on gene frequency, mode of
inheritance and phenotypes.
It is also a common method used for genetic mapping. It uses a DNA
polymorphie marker situated in proximity to a locus causing a disease, and this sarne
locus will be followed during the segregation of the chromosomes in the affected
individuals. This way a LOD score can be determined and linked to a specific gene which
may cause disease. The two types of DNA polyrnorphisms that can be eveluated are
RFLP (restriction fragment length polyrnorphisms) and VNTR (variable number of
tandem repeats). VNTRs are constituted by a variable number of sequence repeated
nucleotides in individuals. This sequence can be short (microsatellites and SSLPs-simple
sequence length polymorphisrn) or long (minisatellites). In order to determine which
polyrnorphisrn was inherited by eaeh individual we use PCR (polyrnerase chain reaction)
and gel eleetrophoresis to detect the repetitions and measure their different lengths. In the
case of genetic linkage studies, microsatellite markers are the most frequently used.
The more a locus marker and a locus causing disease are in proximity to one
another, the more they will travel together and have less recombinance between them.
When these two loci follow one another more ofien than usual during segregation they
are considered to be “paired” or linked. This linkage is quantified with the help of a LOD
score. This is a measure of the probability of a linkage between the disease and the locus.
Generally, a LOD score of 3 is necessary to be deemed significant and indicates a linkage
probability ofp<O.05 between these two loci. (34)
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The resuits of genetic linkage analysis studies are presented in the fonii of a
graphie where the curve represents the LOD score with each of the rnarkers tested ail
along the length of the chromosome. When a significant peak is observed in the graph,
the region which demonstrates this peak contains a QTL (quantitative trait locus). The
localization of a QTL by linkage analysis detenTiines a chromosomal interval of
approximately 20 to 30cM (35). This constitutes a very big region and other methods
must be used to confirrn the QTL and further narrow the number of candidate genes (36).
There is also a possibility that there are rnany QTLs located on the same chromosome. If
the distance separating 2 QTLs is superior to 80cM, these two can then segregate
independently which will be illustrated by two peaks in the graph (37). On the other hand
if the distance separating the two is inferior to 80cM, two peaks will flot be observed and
the presence oftwo QTLs will be undetectable.
Genetic linkage analysis studies are mostly used when studying diseases
implicating only one gene, such as monogenic fonTis of hypertension. In these studies a
mendelian fonTi of transmission is observed and one responsible gene is followed in
affected farnilies. Given the fact that the effects of this gene are present or absent in
certain farnily members, the co-segregation ofalleles causing the disease can be detected.
This type of analysis is very difficuit to use for essential hypertension because it is
the resuit of many genes. The contribution of each gene is weaker and detecting a link
between allelcs causing disease can be more difficuit.
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2.3 Association analysis
Association analysis is an alternative method to genetic linkage which compares
the allelic frequency between the affected and non-affected individuals. If an allele is
found more ofien in affected individuals than in non-affected individuals this allele is
thought to possibly be linked to disease. These studies are more effective than linkage
analysis in studying hypertension because they have greater statistical power to detect
several srnall genes for a srnall effect (37), but they aiso have a greater tendency to yield
false positives.
2.4 Comparative Genomics
This approach employs data from animal studies to identify potential biood
pressure regulating loci in humans. In genetics, a good method to link the animal mode!
to the human is by constructing a homology map. A hornology rnap is constrncted by
placing hornologous genes (found on NCBI) from different species on a map and
comparing their function from one species to another. If the function and importance of
the gene is conserved then that gene and its effects are fiirther studied in depth.
This approach perniits one to target potential QTL regions between species. More
than 70 studies ofhuman populations have identified QTL regions in the human genome.
When animal models are used, a genetic comparison must be applied to be able to locate
the homologous regions in the hurnan genorne. This method also permits us to confirm
the results observed in the animais. In other words when a QTL region is localized in the
animal genome, the conservation of the QTL can be studied by verifying if there is a
superposition of the studied QTL with one which is already identified in the human
genome (figure 4).
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Figure 4- Homology map between the mouse, rat and human.
This figure demonstrates the conservation of the homologous regions and the localization of the QTL
between species. This figure is taken from Etiopoutos et al (52).
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2.5 Genomic Resources
Genornic resources are essential for the genetic analysis of a QTL. Many genomic
resources have been put in place in the last few years with aim to facilitate these genetic
analyses. The most important being the sequencing of the rat genome which was
completed in 2003.
The sequencing of the rat genome was completed in 2003 with more than 90% of
the genome sequenced. This sequence is now readily available at NCBI’s website
(http://www.ncbi.nlm.nih.gov/). In April of 2004, an article published in Nature explains
the key elernents to this sequencing. The Rat Sequencing project, also known as RGSP,
started many years ago. Due to the fact that the rat is often used in rnany physiological
and pharrnacological studies, there was indeed a real need to know its genornic sequence
even thought the rat and mouse are rnorphologically very similar and close ancestors
from an evolutionary point ofview.
Contrary to the genomic sequence of the mouse and hurnan, which are entire
sequences, the sequencing of the rat genorne is flot entirely completed. With sufficient
tirne and funding it should be completed in the near future. This is significant and for this
reason it is very important to keep a high standard in the quaÏity of sequencing in order to
minirnize errors.
The rat genome measures 2.75Gb which is inferior to that of the human genome
which measures 2,9Gb but larger than that of the mouse which measures 2.6Gb. It is
important to remember that the assembling of the genome predicts a size that is always
inferior to the actual size. This is mainly caused by the difficulties of sequencing as well
as assembling the sequenced pieces (38).
26
2.6 Animal models
There exist animal models which were specially generated to represent hurnan
diseases such as hypertension. An animal mode! which suffers from hypertension is less
complex to use. Contrary to hurnan subjects, an animal strain can be crossed in such a
manner that the differences in the genes solely related to hypertension can be studied.
Also, animal models can be analyzed in a controlled environment where many variables,
such as population and environmental conditions, can be pre-determined (39). Animal
models also offer the possibility of a short gestation period as well as a large number of
crosses and progeny which render the study of complex genetic phenotypes and gene
gene interactions casier to study.
2.6.1 The rat
Many rat and mouse models were established to study complex genetic traits.
Such models include consornic, congenic and finally recombinant models (Figure 5).
These strains have been crossed between brother and sister for rnany generations (about
twenty) in order to obtain a good hornogeneity (40). The goal in doing these crosses is to
create strains which are rich in alleles which code for high arterial pressure. In this
mai-mer, some strains are selected for their high arterial pressure while others are selected
for their low arterial pressure (41).
Transgenic models permit the study of candidate gene function by altering the
level of expression of the gene. The targeting of candidate gene expression can be
specific or not (targeting of simple gene). The targeting technique of a simple gene
permits us to abolisli the function of one gene or to duplicate the gene of interest. The
first application of the transgenic model for hypertension was in the mouse. Examination
of candidate genes known for their implications in a signaling pathway which is
irnpÏicated in the control ofarterial pressure yielded an analysis of almost ten genes; these
genes were part ofthe renin angiotensin system.
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More and more researchers use animal models, such as the rat, to aid their
research in hypertension. Today many rat strains exist and each offer their specific
characteristics. Recombinant models are a useful tool in the localization of mendelian
traits. Consomic and congenic models facilitate to target the chromosomal region which
contains the QTL. In consomic models, a whole chromosome is substituted whereas in
the congenic model only a segment of a chromosome is substituted. Consomic models are
widely used to study the effect of the chromosome on arterial pressure. These strains, in
the future, can then be converted to congenic strains. Congenic strains have the advantage
of directly targeting the predetermined QTL region by using linkage analysis studies. The
QTL regions can then be easily reduced by fabricating other congenic sub-strains.
Figure 5 — Genetic tools using the rat
Based on a representation from McBride et al (2003) (48)
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Even though the rat bas been known to transport dozens of diseases and is
comrnonly known as a pest, it bas contributed a great deal to hurnans and their health by
helping us to better understand the complexity of human diseases. The laboratory rat also
known as Rattus norvegicus originated from central Asia and is one of the first mammal
species to be domesticated for scientific research in 1 $2$ (42).The first genetic studies
using the rat studied the color of their fur as a mendelian transmission trait (43). Even
thought studies using rats had a very promising beginning, the mouse quickly became the
model of choice for genetic studies in mammals. In contrast, the rat stiil remains the
model of choice for research in physioiogy, nutrition, as well as other biomedical
research where more than 235 rat strains are used.
The Dahi Sait-Sensitive rat (Table II) is an example of an available strain used in
hypertension research. In 1963, Dahi started crossing rats which were seiected for their
sensitivity (S rat) and resistance to sodium (R rat) (47). Rapp then foilowed by creating
strains which were a cross between brother and sister, therefore creating a prototype
model for the study of hypertension (45). The S rats dcveiop hypertension with a iow sait
diet but this hypertension is significantiy augrnented when a high sait diet is introduced (2
to 8% NaCÏ).
During the selection of rats which were sensitive to sait, other rats were selected
specificaiiy for their resistance to sodium. One such strain was the Lewis rat (Lew) which
dernonstrated a high resistance (46). This is surprising because Lew rats had previousiy
not been selected for their resistance to sodium. In addition to having a high resistance to
sodium, 45% of the microsatellites from the Lew genome are polymorphie with those of
the S genome. In the case of the R rats, oniy 18% ofthe microsatellites were polymorphie
with those of S (44). A larger percentage of polymorphic microsateliites increases the
quality of genetic linkage.
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Hypertensive or Normotensive Abbrev. Origin Reference
Strain
Geneticaliy hypertensive GH Dunedin, New Smirk et Hall, 19581
Zealand
Dahi sait-sensitive S, DS, SS/Jr Brookhaven, USA Dahi et al., 1962
Dahi sait-resistant R, DR, R/Jr
DOCA sait-sensitive SBH Jerusalem, lsrael Ben-Ishay et al., 19728
(Sabra hypertensive)
DOCA sait-resistant SBN
(Sabra normotensive)
Lyonhypertensïve LH Lyon,France Dupontetal., 1973
Lyon normotensive LN
Lyon iow biood pressure LL
Spontaneous hypertensive rats SHR Kyoto, Japan Okamoto et Aoki, 1963
Spontaneous hypertensive rats — SHRSP Kyoto, Japan Okamoto et al., 1974
stroke prone
Milan hypertensive MHS Milan, ltaly Bianchi et al., 1974
Milan normotensive MNS
Fawn-hooded hypertensive FHH Utrecht, Germany Kuijpers et Gruys, 1984
Fawn-hooded iow biood pressure FHL
inherited stress induced arteriai ISIAH Novosibirsk, Russia Markel, 1985
hypertensive
Prague hypertensive PHR Prague, Czech Heller et aI., 1993
Praguenormotensive PNR Republic
Table II- Strains of rats selectively developed for the study of hypertension
Table adapted from Rapp et al (47)
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Chapter 3
Study of genetic linkage analysis
A genetic linkage study is based on the co-segregation of which occurs inside a
certain population. To explain co-segregation and genetic Iinkage in mammal models,
Rapp has given an example using 2 contrasting strains for each studied phenotype, which
in this case is arterial pressure. In the example lie uses, these are called Pi and P2 (47).
The M marker is a microsatellite for tlie M locus whicli is Iinked to QTL A for arterial
pressure (figure 6). The Al ailcie of the Pi strain is tlie allele tliat dirninislies tlic arterial
pressure, whereas the A2 allele of the P2 strain is the allele that augments the arterial
pressure. In this example, we have the Ml marker which is linked to QTLA on the Ai
allele whicli dirninishes arterial pressure and the M2 marker linked to QTLA on the A2
allele which raises the arterial pressure. Due to the fact that these two strains are
produced from brotlier-sister crosses for many generations, the rnarkers and loci are both
homozygous for their alleles. Meaning that the studied gene or trait is followed through
generations by following the specific rnarkers whicli are Ïinked to the alleles in that
strain.
A large population is necessary to do a genetic linkage study. An fi population is
obtained by crossing the Pi and P2 strains. The F2 population is obtained by inbreeding
the Fi population. The f2 population is then phenotyped for arterial pressure (in the case
of our studies by telemetry) and genotyped using PCR with a microsatellite for the locus.
During these crosses, the markers and alleles segregate using Mendel’s tlieory (1:2:1).
The arterial pressure observed is compared using statistic tools (sucli as ANOVA). In this
example differences in arterial pressure will be observed because the marker is linked to a
QTL for arterial pressure. The bigger the distance between tlie marker and the QTL, the
higher tlie possibility of a recombinance. This diminishes the possibility of co
segregation of M witli the arterial pressure.
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Lignée P1 Lignée P2
M1 A1 M2 A2
M1 A1 M2 A2
Pi X P2
(M1M1) (M2M)
F1
(M1M2)
F1 x F1
(M1M2) (MM)
F2
(1 M1 M1; 2M1M2; 1M2M2)
figure 6- Co-segregation during linkage study
Picture based on a representation of article by Rapp et al.
The next step in a genetic linkage study is to localize the QTL on a chromosomal
map and to identify the influence of this QTL on the arterial pressure. The potency of a
QTL can bring upon difficulties in finding its exact position. For example, an effect on
arterial pressure linked to a specific marker can be caused by a QTL which is situated in
proximity to the marker used in the study, or to a QTL situated at a greater distance from
the marker. This ïs due to the fact that the QTL’s influence on arterial pressure is so large
that it is observed to be Iinked to the marker which is situated farther.
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Many statistical tools have been put in place to facilitate the localization of a
chrornosornal QTL. One such tool is MAPMAKERJQTL(48). This program predicts the
possibility of the presence of a QTL by calculating logarithrns where a resuit is obtained
under a LOD connotation. A LOD is a log ratio of the possible presence of a QTL versus
thc possible absence of a QTL. The resuits obtained by these calculations are presentated
in the fonu of a graph where the LOD is calculated at rnany intervals between the
rnarkers. The graph has the chrornosornal positions on the x axis and the LOD score on
the y axis. The interval where the LOD score is the highest is the chromosomal region
which is the most susceptible of containing a QTL for arterial pressure. A LOD score
higher than three is deemed significative. The interval of confidence is influenced by
rnany factors such as the strength of the QTL on the observed phenotype, the size of the
studied population and the density of the rnarkers used.
Even if these factors are taken into consideration during the preparation of an
experiment, the localization of a QTL by genetic linkage only lirnits us to a chrornosornal
interval of approxirnately 20 to 30 cM (49). $uch a region contains hundreds of genes.
Researchers then have to use to use another rnethod to reduce the number of candidate
genes.
Another problem which arises during genetic linkage studies is the analysis of
information obtained from LOD curves. There is always a high possibility ofthe prcsence
of rnany QTL5 on a single chromosome. If the distance separating these two QTLs is
superior to 80cM then there is a chance that these two QTLs segregate in an independent
manner. This can be observed by two peaks on the graph. In the opposing case, if the
difference separating the two QTLs is inferior to 80cM, the curve will not indicate the
presence ofmany QTLs due to the fact that only one peak will be observed.
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The presence of rnany QTLs on a single chromosome can also indicatc a
possibility of an interaction arnongst them. If the interaction is additive, we may observe
an amplification or a canceling out of the LOD score. In the first case, both QTLs have an
effect of increasing arterial pressure then a high LOD score for a specific locus will be
obtained. Therefore, by isolating the locus, there is a high possibility that’s its effect on
arterial pressure will not be as significant as previously noted. A canceling out of a LOD
results from an additive interaction of 2 QTLs with opposite effects on AP.
Epistatic interactions are another form of interaction that QTLs may have. Such
an interaction is common for complex traits but also difficult to identify due to the fact
that it may give a non-significant LOD score. This kind of interaction will be explained
in more detail fiirther in this thesis.
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Cliapter4
Congenic Strains
The presence of a blood pressure QTL on a chromosome cannot be proven simply
by assessing a genornic study (50). With genetic linkage analysis studies, a very large
QTL region is obtained. This region is too big to justify positional cloning and statistical
analysis of these studies also present certain interpretational problems. Therefore, a
physiological study must be done to show that the rcgion predicted by the genornic study
really does have an effect on arterial pressure. To accomplish this, we use congenic
strains which pernit the molecular study ofthese QTLs (51).
Congenic strains permit us to target a region of interest in the animal genome
(Figure 6). The following example which was given by Rapp explains the construction
of a congenic strain. The donating strain bas a M1M1 genotype for the marker in the M
locus. The receiving strain has a M2M2 genotype for the marker in the M locus. The
receiving strain means that the genetic background of the congenic strains wiÏl come
from this genotype and that this strain will accept the homologous segment of the
donating strain. In this example, the goal is to obtain a genetic background of M2M2
genotype with a chromosomal M1MI region. An Fi population is produced by crossing
thcse two sixains. This population will have a M1M2 genotype. The population is then
crossed with the receiving strain. A population with the genotypes M1M2 and M2M2
will then be obtained. The heterozygotes will again be selected to be bred once more with
the receiving sixain. This backcross is done eight times in order to assure the
homogcneity of the genetic background (52). Once the genetic background is
homogenous, two MIM2 heterozygotes for the targeted region are intercrossed. We then
obtain a population with a genetic background homogenous to the M2M2 genotype and
having M1MI, M1M2 and M2M2 genotypes for the targeted region. The rats which
contain M1MI for the region ofinterest are then chosen for the quantitative studies ofthe
studied trait.
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Due to the many backcrosses, congenic strains take between two and four years to
construct. With a arger amount of avallable rnarkers in the rat, the amount of tirne
necessary to construct congenic strains can be shortened by using the speed congenics
method (53). This method uses rnarkers dispersed throughout the genome, as well as the
rnarkers in the region of interest, to genotype the rats. This method perrnits to obtain
congenic strains in a matter of 15 to 18 rnonths (figure 7).
Consequently, by constructing many congenic sub-strains for a QTL region we
succeed in localizing the blood pressure QTL. $adly, the srnallest possible region we can
identify using this rnethod is I cM because the possibility of recombination between two
nearby rnarkers is low (54). Once the QTL region is reduced to 1cM, positional cloning
can then start. Many articles have bcen published with QTL for blood pressure localized
and reduced thanks to congenic strains (55-65).
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Figure 7- Schematic representation of the construction of congenic strains.
The parent strains S and Lew are crossed to obtain the heterozygous Fi population. This population is
recrossed with th parental S strain. We then obtain the Ni population which is genotyped and the rats
which are heterozygous for the markers flanking the chromosomal targeted region. A series of backcrosses
are performed with these rats to obtain a population which is heterozygous (SL) for the targeted region and
homozygous for the genetic background. The brothers and sisters having these characteristics will be
crossed w obtain an $5 descendance for the chromosomal background and LL for the targeted region. The
rats are then crossed to obtain a stable congenic strain. Picture based on a representation from article by
Cowley Jr et al (73)
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Figure 8- Method used to obtain rapid congenic strains (speed coltgenics)
The bacboss generations are reduced by approximately 50%. This approach uses polymorphic markers
dispersed throughout the genome in equal intervals. figure from McB ride et al. (2003) (26).
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Chapter 5
QTL Mapping
Before the sequencing of the rat genorne, finding rnarkers in the region of interest
was more or less a question of chance. Many versions of genetic linkage and radiation
hybrid maps have been published. These versions vary depending on the markers which
are positioned and the distances between them. Therefore, the rnarkers must not only be
poÏymorphic but also situated at the right position and one lias to integrate information
from many maps.
This rnethod is stili widely used today but it is facilitated by the use of genornic
sequencing. Thanks to this technique, it is now possible to position the rnarker on a
chromosomal map with high precision. The main obstacle that one does face are the
“holes” on a genetic linkage map (meaning a region on map where no polymorphie
marker has been found). In the recent past the number of “holes” bas been significantly
reduced.
However, it is very important to note that the information obtained through the
genomic sequence is not a certainty. By aligning the sequence of a marker with the
available genomic sequence we obtain the markers position on the chromosome.
Nevertheless, it is only by genotyping the marker using the congenic strains that we can
confinn its position on the chromosornal map.
A genetic map which is rich in markers perrnits us to characterize the congenic
strains with higher precision. This is accornplished by having a smaller distance between
markers and therefore reducing the ambiguous regions. Smaller ambiguous regions in
congenic strains facilitate the localization of the QTL by dirninishing the QTL region.
Many groups have demonstrated that a larger number of markers used in their studies
have aided the localization ofblood pressure QTLs. (66-68)
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5.1 Microsatellites
Microsatellites are short tandem repetitions found throughout the non-coding
genome of eukaryotes. These repetitions appear to be due to siiding during DNA
replication (69). These repetitive sequences can be under mono-, di,-, tri or
tetranucleotide form. Microsatellites vary in length and can be genotyped by a simple
PCR reaction.
By comparing the human genome to the mouse genome, one notices that there are
more microsatellites in the mouse genome. Also, these microsatellites have a tendency to
be longer. On the other hand, when comparing the mouse and rat genomes, the
differences are less noticeable.
S L
Figure 9-Example of PCR genotyping
An example of genotyping done by PCR demonstrating a heterozygote (SL) and a homozygote (SS) and
controls on the righ[ hand side.
Unpublished data V. Eliopoulos et al (2005)
With the sequence of most genes now available to any laboratory, the list of
oligonucleotides used to amplify microsatellites by PCR have now become more
extensive. Certain laboratories have now specialized in the identification and
characterization of microsatellites and the synthesis of oligonucleotides which are
necessary to amplify them. This work creates a large database for microsatellite use.
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These microsatellites are in turn used to make genetic linkage maps. These maps
have been established for each chromosome of the rat. These microsatellites allow
researchers to place their target on a chromosome, thus calling them genetic markers. For
a specific marker to be useful, it must be polymorphie for the strain of rat which is
studied.
Many marker databases are available on the Internet (Table 3). This information
can be under the formn of a table or a map. In these tables or maps, one can find the
approxirnate positions of the chromosomal markers. There are also databases which offer
information on marker polymorphism, their optimal temperatures for PCR and finally the
oliginucleotides used in PCR amplification.
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Tools Internet site
http ://ratmap.hgc .j p[Marker_search.html
http://www.broad.mit.edulrat/public/
Genetic http://www.broad.mit.edu/rat/publicI
markers http://www.well .ox .ac .uratmappingresources/markers_info/
http://ratmap.org/ResuttSearchLocus. htm?citno=666v
http://www.well.ox .ac .uklrat_mapping_resources/marker_polytest.html
http://www.niams .nih.gov/rtbc/ratgbase/dataJARBPR3 .htm
http://ratmap.hgc .jp/comp.html
Genetic http ://ratmap.hgc .jp/menu/maphtm1
linkage maps http://ratmap.org/ChromapnyPh.html
http://ratmap.org/Idiogram.html
http://ratmap .orglgene_mapping_datalintegrated_Iinkage_maps/
http://rgd.mcw.edu/tools/maps/maps_view.cgi ?id= 1 006&chr=3
http://www.well .ox.ac .uklrat_mappingjesources/rat_RH_comprehensive_maps .html
Hybrid http://www.broad.mit.edulrat/public/
radiation maps http://www.rgd.mcw.edu/tools/maps/maps_view.cgi ?id= 1002
http://www. wetl oxac uk/rat_mapping_resources/rat_RH_framework_maps.html
Table III - Examples of Internet sites used to find marker information
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5.2 Physical Maps
What was before considered a long and tedious task has now been simplified by
the availability of the rat genornic sequence on the internet. Contrary to the genetic
linkage rnaps or the hybrid radiation maps, where the distances are expressed in cM and
cR respectively, a physical map gives the distances between rnarkers and genes in ph.
Before the availability of the rat sequence, a physical rnap was nothing but an
estimation of the distance between two rnarkers. This approxirnate distance was obtained
by aligning the bits of BAC and YAC which were available.
By having the larger fragments of the genomic sequence regrouped in
supercontigs, determining the chromosornal position of a rnarker and the distance
between two rnarkers is rnuch more precise. This can be accornplished by using a
program called B LAST (http ://www.ncbi .nl rn .nih.gov/BLAST) which is available on the
NCBI website.
Due to the fact that the genornic sequence of the rat was neyer really cornpleted,
sorne gaps or holes will always remain, thus leaving the possibility of elTors. This can
sometirnes cause false resuits for certain alignrnents or even an absence of alignrnent for
certain sequences.
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5.3 llomology Map
A liomology rnap lias rnany ftinctions, one of them being the identification of tlie
chromosomal region of the liurnan genorne irnplicated in tlie trait studied and the second
obtaining a more complete list of candidate genes.
To identify the region irnplicated in tlie liurnan using rat studies, one establishes
limits to each region. The alignrnent of sequences, as previousÏy rnentioned, is one of tlie
methods used. It is important to remember that during evolution large chrornosornal
segments remained intact. This fact greatly facilitates the construction of a homology
rnap. By aligning the sequences of the region of interest of the rat to tliat of the mouse
genome, we then obtain a homologous region in tlie mouse. It is advised to first align the
sequences of the rat and mouse and then those of the human because the first two are
known to be evolutionary cousins.
Due to the fact that the genornic sequences are more complete in the mouse than
the liuman, a liomology map permits one to obtain a more precise list of candidate genes
which are in the region of interest in the rat genome. The list of genes in tlie region of
interest can be viewed by looking at tlie text version of the sequence on the NCBI site
(http://www.ncbi.nlm.nih.gov/) or by using the MAPVJEWER program on this site. The
MAPVIEWER program flot only offers a visual version of the genome with the
placement of genes, but also pennits one to obtain information on the specific gene and
its known liomology in other species.
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Chapter 6
Previous studies
Michael R Garrett’s team bas previously done a genetic Ïinkage study for essential
hypertension by using two rat strains (70). In order for this study to be done, the two
strains used must have contrasting phenotypes for the studied trait. Thercfore, the Dahi
Sait-Sensitive rat (S rat) and the Lewis rat (L rat) were used in their genornic study of the
rat for blood pressure QTLs. In their study, a population of 151 rats were used as well as
406 rnarkers which were spread out throughout the genorne. These rnarkers covered
97.3% ofthe genorne and were separatedby an average distance of 10cM.
For chromosome 2, 30 genetic markers were used to cover the length of the
chromosome. Initial linkage studies indicated that a blood pressure (BP) QTL was
probably present in a segment between D2Mit6 and D2Mcol9 markers based on an
f2(DSS x LEW) population (71). The detection of this QTL was supported by a
maximum LOD score of 2.9 (71), and thercfore, was stiil below what was considered the
highly significant level for detecting a QTL (LOD score of three) in such a population
(72). An obvious question to ask oneseif is ‘could this detection be a true localization of
a BP QTL?’ Moreover, Stoll and coworkers (73) detected QTL5 for several
physiological phenotypes in the vicinity of the BP QTL on Chr 2 found in our f2(DSS x
LEW) population (71). This region, therefore, could potentially harbor important genes
not only for BP, but also for other physiological traits. Another question which remained
was if the gene encoding the angiotensin receptor type AT1B (Agtr] b), which is included
in this area, could represent a candidate gene for the QTL?
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Figure 1O-Previous linkage analysis studies
This figure demonstrates different linkage analysis studies which were done using various strains which
localize the QTL in different regions depending on the strains studied. The f2 populations using the LEW
and S rat were the ones which were of interest to us. This linkage analysis predicts a blood pressure QIL to
be between the PRLR marker and D2Ratl 8. Taken from Rapp et aÏ (70).
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Chapter 7
Project
In order to find out if chromosome 2 does indeed contain a blood pressure QTL
we used the congenic strain method. We constructed congenic strains using the same two
strains used in the linkage analysis because variation can sometimes occur between the
strains of rats used.
Four congenic strains, C2S.L1, C2S.L2, C2S.L3 and C2S.Y (FigurelA), were
constructed and purposely designed to overlap each other in chromosomal coverage, but
in the meantime, leave no gaps uncovered for the entire region of interest predicted by
previous studies. C2S.L3 was to include the gene Agtrlb for the specific purpose of
testing its candidacy for a BP QTL. The arterial pressure of the rats was then measured
using telemetry.
CALENDAR
I I f I I Iw D Day5l Day86 Hay 30 Weaning Telemetry probes HBiiths
implantation
Day3$ Day65 Day 103
Identification a of high Telemetry:
Day 21 sait diet measurement
Parents 2%NaCl 0f BP
seperated
‘Il
Day 123
Sacrifice
Only male
rats are used
in telemetrv -
Figure 11-Telemetry
Example of timefrarne and techniques followed in order to have consistent resuits in telemetry.
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After constructing the first congenic strain (C2SL1) we had to further narrow the
region, therefore we constructed C2SL2 and C2SL3. Once it was noted that the blood
pressure of C2SL2 and C2SL3 did flot vary from that of DSS, we then continued to
construct C2SL4. In our studies we found that SAPs, DAPs and MAPs of C2S.Ll and
C2S.L4 were higher (p<O.003) than those of D$S (Figure 2A). In comparison, MAPs,
DAPs and SAPs of C2S.L2 and C2S.L3 were flot different (p>O.l2) from those of the
D$S strain (Figure 2A). Consequently, the region containing the QTL, C2QTL4, can be
localized to the segment that was in common between C2S.L1 and C2S.L4, but flot
included in C2S.L2 and C2S.L3 (Figure lA). This segment is between D2Chm277 and
Prir (Figure 1A).The interval of D2Chrn277/PrÏr was calculated to be about 3 megabases
(Mb).
What differentiates this study from others is the fact that in this QTL, the alleles
of the QTL from the LEW rat actually raise blood pressure. This is contrary to common
assumptions where the alleles of the LEW rat are nornrntensive. This is explained in
better detail further on.
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Abstract
Pursuing fully a suggestion from linkage analysis that there rnight be a
quantitative trait locus (QTL) for blood pressure (BP) in a Chromosome (Chr) 2 region of
the Dahi sait-sensitive rat (DSS), four congenic strains were made by replacing various
fragments of DSS Chr 2 with those of Lewis (LEW). Consequently, a BP QTL was
localized to a segment of around 3 centiMorgan (cM) or near 3 megabases (Mbs) on Chr
2 by comparative congenics. The BP-augmenting alleles of this QTL originated from the
LEW rat, a hypotensive strain cornpared to DSS. The dissection of a QTL with such a
paradoxicai effect illustrated the power of congenics in unearthing a gene hidden in the
context of the whoie animal system presumabiy by interactions with other genes. The
iocus for the angiotensin II receptor ATI B (Agtr] b) is not supported as a candidate gene
for the QTL because a congenic strain harboring it did not have an effect on BP. There
are approximately 19 known and unknown genes present in the QTL-interval. Among
them, no standout candidate genes are reputed to affect BP. Thus the QTL wiil likely
represent a novei gene for BP regulations.
Key words: comparative congenics, fiinctional genomics, biood pressure, fine mapping
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Introduction
Our initial linkage studies indicated that a BP QTL was probably present in a
segment between D2Mit6 and D2Mcol9 rnarkers based on an f2(DSS x LEW)
population (16). The detection ofthis QTL was supported by a maximum LOD score of
2.9 (16), and therefore, was stili below what was considered the highly significant level
for detecting a QTL in such a population (19). An obvious question to pose is ‘could
this detection be a true localization of a BP QTL?’ This issue is important because
linkage analysis is usually the first step in localizing a QTL for complex traits on Chr2 (3;
6; 9-1 1; 24; 26; 27; 30). Moreover, Stoil and coworkers (29) detected QTLs for several
physiological phenotypes in the vicinity of the BP QTL on Chr 2 found in our F2(DSS x
LEW) population (16). This region, therefore, could potentially harbor important genes
not only for BP, but also for other physiological traits.
Based on above considerations, there were several questions to be addressed: (a),
Did a BP QTL exist in a region detected by linkage analysis (16)? (b), 1f it did, does
LEW possess BP-raising alleles, and can the gene encoding the angiotensin receptor type
AT1B (Agtr] b) be supported as a candidate gene for the QTL? The present investigation
was intended to address these two questions and to fine map the QTL in question.
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Materials and Metliods
Animais and generation of congenic strains: The breeding procedure, markers
used in genomic scans, and the screening protocol for generating congenic strains were
essentiaily the same as reported previousiy for mapping BP QTLs on other chromosomes
(2; 7; 20-23; 28). For our current work, four congenic strains were produced, and are
designated as DS S .LEW-(D2Ratl 99-D2Ratl 43)/Lt (abbreviated as C2S il), DS S.LEW
(D2Ratl 8-D2Chrn277)/Lt (C2S .L2), DSS.LEW-(PrÏr-D2Ratl 43)/Lt (C2S .L3) and
DSS.LEW-(D2Rati99-D2Mcol7)/Lt (C2S.L4) respectively. C2 indicates that the strain
is made for Chr 2. The chromosome regions hornozygous LL in the congenic strains are
shown as solid bars in Figure 1. Ail the markers in the region concerned were genotyped
in the congenic strains.
Production of new markers: The process is sirnilar to what was reported
previousiy for other chromosomes (2; 21; 22). The PCR primers for the ncw D2Chrn
markers used in the present studies are given in the legend for Figure 1.
Breeding protocol for BP studies: The determination of BPs is essentially the
same as described previousiy (2; 7; 12; 13; 20-23; 28). In brief, the mating pairs ofthe
DSS and congenic strains to be studied were bred simultaneously. Maie rats were
selected and weaned at 21 days of age, maintained on a iow sait diet (0.2% NaC1, Harian
Tekiad 7034) and then fed a high sait diet (2% NaCi, Harian Tekiad 94217) starting from
35 days of age untii the end of the experiment. Teiemetry probes were impianted whcn
rats were 56 days oid (i.e. afier 3 weeks of the high sait diet) with their body weights
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between 250-320 grams. Afier the surgery, the rats were allowed 10 days to recuperate
before their BPs were read. The implantation of telemetry probes, the age and
postoperative cares of animal are the same as described before (12; 13).
BP measurements: The basic protocol was sirnilar to our previous congenic work
regarding the age and sex of the rats, and in terms of the tirnetable of dietary treatrnents
(2; 7; 12; 13; 20-23; 2$). One BP reading was taken every 2 minutes for the period of
measurement. Then, these readings were averaged for 6 hours to obtain one data point,
which appears as a point on the graph for the purpose of showing diumal variations
(Figure 2). Please see Dutil and Deng (12) for detailed comparisons in BPs ofDSS and a
congenic strain exhibiting even finer variations during our typical BP measurements.
Statistical analysis: Repeated measures’ Analysis of variance (ANOVA) followed
by the Dunnett test in the SYSTAT 9 program (SPSS Sci. Chicago, IL) was used to
compare the significance level for a difference or a lack of it between a congenic strain
and the D$S strain. The Dunnett test takes into account multiple group comparisons as
well as sample sizes among the comparing groups. In the analysis, a BP component was
compared at each day for the period ofmeasurement among the strains (2; 7; 12; 13; 20-
23; 2$).
As BPs of rats were measured continuously for about 2-3 weeks and varied with
time, the numbers given at the bottom of Figure 1 represented only averaged values of
mean arterial pressures (MAP) for a strain, and did not reflect the day to day BP
variations. A Dunnett value including’<’ given in each comparison between a congenic
and DSS strains was the most conservative p value among ail the days ofcomparisons.
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Resuits
Congenic constructions: A total of eight rats with various crossovers in the
regions of interest were obtained. Arnong them, two rats died before yielding any strains
and six rats eventualÏy gave rise to six congenic strains. Arnong them, two contained
chromosome fragments inside those of C2S.L2 and C2S.L3 (figure 1). Since both
C2S.L2 and C2S.L3 did not exhibit B? effects (Figure 2), these two congenic strains
were discarded.
The four congenic strains, C2S.L1, C2S.L2, C2S.L3 and C2S.L4 (Figure 1), were
designed to overlap each other in chromosome coverage, but in the meantime, leave no
gaps uncovered for the entire region of interest. C2S.L3 was to include the gene Agtr]b
for the specific purpose oftesting its candidacy for a BP QTL.
BP Studies: Ail the BP components were measured inciuding systolic (SAP),
diastolic (DAP) and mean arterial pressures (MA?). BPs for ail the strains shown in
Figure 1 were measured at least at two different times, i.e. they were separate litters
raised at various times during a period of one year. This consideration was designed to
minimize the environmental influences on the phenotyping accuracy. The resuits showed
that BPs for each strain, C2S.L1, C2S.L2, C2S.L3, C2S.L4 and DSS, were not different
at the separate periods of measurements (data flot shown). Therefore, the BP data for
each strain were pooled from these reproducible measurements (Figure 2).
Mapping of a BP QTL by comparative congenics: SAP, DAP and MA? of LEW
were lower (p<O.00Ï) than those ofDSS (Figure 2); in contrast, SA?s, DA?s and MA?s
of C2S.L1 and C2S.L4 were higher (p<O.003) than those of DSS (Figure 2). In
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comparison, MAPs, DAPs and SAPs of C2S.L2 and C2$.L3 were flot different (p>O.l2)
from those of the DSS strain (Figure 2). Consequently, the region containing the QTL,
C2QTL4, can be localized to the segment that was in common between C2S.L1 and
C2S.L4, but not included in C2S.L2 and C2S.L3 (Figure 1). This segment is between
D2Chrn277 and Frir (Figure 1).
The interval of D2Chm277/PrÏr was calculated to be about 3 megabases (Mb) as
follows (Figure 1). D2Chm277 is at the position of 1.9 Mb in supercontig 47621.1 (with
1.9 Mbs total), FrÏr is at the position of 2.9 MB in supercontig 47622.1. The QTL
interval would be 2.9 Mb plus a gap with unknown number of bases between the two
supercontigs. Calculating from the distance of cM 12.7 divided by l3Mbs in physical
distance between C2Mcol3 and Frir (Figure 1), 1 cM = 1 Mb. Thus, the C2QTL4
interval of 3 Mbs is about 3 cM.
Systernatic comparative mapping in search of candidate genes: Possible genes in
the QTL interval are included in Figure 1 by comparative mapping among the rat, mouse
and human genomes at http://www.ncbi.nlm.nih.gov/mapview/. Figure 3 synthesizes the
QTL localizations so far documented in the literature, and places the present QTL with
reference to the others.
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Discussion
Major findings ofthe current work are (a) LEW carnes high-BP alleles and DSS
carnes low-BP aÏÏeles at C2QTL4, despite that LEW is a normotensive strain, whereas
DS$ is a hypertensive strain. The congenic strain, C2S.Ll and C2S.L4, can be classified
as a ‘DSS’ strain with severe hypertension. (b) The position of C2QTL4 bas been
restricted to an interval of 3 Mbs (or around 3 cMs) by comparative congenics, i.e.
comparing the two congenic strains that had, with two that did not have, BP effects. The
QTL intcrval harbors 19 possible genes, 4 known and 15 undefined Locs (Figure 1). This
size is amenable for positional cloning. (e) Agtrlb bas been disqualified as C2QTL4
because C2S.L3 had a BP flot distinguishable from that of DSS. Since no apparent
candidate genes are found in the segment harboring the QTL, the QTL discovery will
inevitably lead to the identification of a brand-new gene previously unknown to influence
BP.
BP of DSS could be raised by substituting alleles of C2QTL4 by those of LEW
(figures 1 and 2). Although LEW contains C2QTL4 alleles that exert BP-elevating
effects, paradoxicaÏÏy, BP ofthe LEW strain itselfis considerably lower than that ofDSS
(Figure 2). This fact indicates that it is not a single QTL, but rathcr it is how this QTL
interacts with others, that deterrnine the overali BP of a strain. Among the mechanisrns
of interactions, one can be epistasis. For example, the two QTLs on Chr 3 possessed
opposing BP effects, one decreasing and other increasing BP (22). Yet the cornbined
effect of these two QTL was equal to that of the QTL that decreased BP (22). This
epistasis implies that these two QTLs acted in the same pathway/cascade leading to BP
deterrnination (4; 5). In addition, the numerical advantage of BP-decreasing QTLs rnight
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have outweighed and nullified the effect of fewer BP-increasing QTLs in LEW, since
there have been more BP-decreasing QTLs found in LEW than in DSS (4).
C2QTL4 is Iocalized to the Chr 2 segment between D2Chm277 and FrÏr rnarkers
because C2S.Ll and C2$.L4 did, whereas C2S.L2 and C2S.L3 did not, have BP effects
(Figures 1 and 2). This approach of comparative congenics in placing a BP QTL is
consistent with our other work in mapping C10QTL2 and C1OQTL3 on Chr 10 (23) and
in mapping two QTLs in the lower part of Chr 2 (Figure 3). For example, using the same
approach, we initially localized C2QTL1 to a 5.7 cM segment of none overlapping
between a congenic strain that had and a congenic strain that did not have a BP effect on
Chr 2 (13). Later, a congenic substrain specifically involving the 5.7 cM region proved
that, indeed, there was a BP QTL in the region (14). In une with this expectation, an
eventual proof that C2QTL4 is present in the fragment shown in Figure 1 will corne frorn
making a congenic strain that specifically involves the interval of D2Chml45/PrÏr. A
congenic substrain trapping the QTL with a ‘minimum’ chromosome coverage (e.g. 1 cM
or less) is desirable flot only for the proof of its existence, but also for its final molecular
identification.
The possibility of finding more than one QTLs in the fragment between
D2Chm277 and Prir (Figure 1) can flot be excluded. Only further fine congenic mapping
can resolve this issue. There is evidence that more than one BP QTL5 were present close
to each other in the lower part of Chr 2 (Figure 3), on Chr 10 (23), on Chr 3 (22), on Chr
$(2),onChr5(17)andonChrl (l5;25).
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It is worth noting that Agtr]b is flot supported as a candidate gene for the QTL
because congenic strain C2S.L3 harbors it, and yet, did flot show a BP effect (figures 1
and 2). A thorough comparative mapping among the rat, the mouse and the human
genomes did flot reveal obvious candidate genes known to influence BP in the interval of
D2Chrn277 and FrÏr containing the QTL (Figure 1). Thus, it is rnost likely that this QTL
will represent a nove! gene for BP regulation.
Since our initial work (6; 10; 16), rat Chr 2 lias been shown to contain QTLs with
BP-raising alleles originating from various hypertensive rat models (1; 3; 18; 24; 27; 30).
These QTLs are rnostly clustered in the region between D2Rat303 and D2Mghl2
rnarkers in the lower part of the chromosome (figure 3). C2QTL4 identified in our
current work seems to be unique in its chromosome location and, in contrast to other BP
QTL5, in its BP-decreasing effect from DSS.
The existence of C2QTL4 found by linkage (16) followed by the current congenic
confirmation was in contrast to the statistical detection (6; 9) and subsequent non
confirmation (13) of another QTL near Agtr]b (9), which compared DSS to the Milan
norniotensive strain (MNS). The latter outcome could probably be attributed to a false
positive of statistics in our linkage resuits in the F2(DSS x MNS) population (6; 9).
Thus, it is essential to verify the existence of a QTL by congenic strains afier linkage.
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In conclusion, there is a QTL(s) for which BP-raising alleles originate,
paradoxically, from the nonriotensive LEW strain in stead of the hypertensive DSS strain
on Chr 2. This QTL can act independently from other QTLs in the context of the DSS
background. Genes located in the QTL interval are not known to affect BP. Therefore,
the gene discovery on this QTL will unravel nove! mechanisrns controlling pathogenesis
of hypertension.
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Figure lB. Fine mapping of C2QTL4. The linkage map is essentially the same as
published previously, which is a composite rnap of Chr 2 (8). Soiid bars under congenic
strains symbolize the DSS chromosome fragments that have been replaced by that of the
LEW rat. The entire region indicated by solid bars and junctions between the solid and
open bars are hornozygous for LEW, i.e. LL, on the map for ail the markers listed in the
corresponding positions. Open bars on ends of solid bars indicate the ambiguities of
crossover breakpoints between markers. Agtr]b, angiotensin receptor type AT1B; Frir,
prolactin receptor. The rest ofthc rnarkers are anonymous.
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Primers for the new D2Chm markers are as foÏlows: D2Chml45 (forward
5’ ggggagagtttcaaccctactt 3’, reverse 5’ ggacccaatcggctcttaat 3’); D2Chrn 149 (forward 5’
ttctgccttagtccccagtc 3’, reverse 5’ cctgcctaatttgcttttgg 3’); D2Chrnl72 (forward
S’gtggccagggactgagaata 3’, reverse 5’ cgtgaagagagggaacctca 3’); D2Chrnl75 (forward 5’
ccagccactttgctgaagtt 3’, reverse 5’ ccccagctctggtaaacact 3’); D2Chm 191 (forward 5’
tttccatgaatcctggcagt3’, reverse 5’ aaagccacatgccaattctc 3’); D2Chm 192 (forward 5’
acagcagacattcgcaagc 3’, reverse 5’ agcagacacaaccctgagt 3’); D2Chm 229 (forward 5’
aaagctgccacgaacaatct 3’, reverse 5’ tggacctaagtcccaaagga 3’); D2Chrn233(forward 5’
tgggtcccacctctagacac 3’, reverse 5’ ggccactttgtgctggataa 3’); D3Chrn238(forward 5’
ggatagccagggctacataga 3’, reverse 5’ cccatagggcccaatagttc3’); D2Chrn277(forward 5’
tcactggctcaaaagcctct 3’, reverse 5’ ggttgtaagttagaatactccccatc 3’); D2 Chrn27 8 (forward 5’
tctctgtctctgcccctacc 3’, reverse 5’ ctccaaaagagccgagtgtc3’); D2Chm2 8 O(forward 5’
ccatagaaagatcacccttgc 3’, reverse 5’ tgggttcttactgacaaagatgc3’); D2 Chrn2 8 9(forward 5’
cagcagaaatgcttgcctaa 3’, reverse 5’ tgacaagcaggaatagcctct 3’); D2Chm294(forward 5’
ggcagaggcaggtgaatcta 3’, reverse 5’ tcacagagactatggcagactga 3’); D2Chm296(forward 5’
tgtgcagccatggtacaaat 3’, reverse 5’ ccttttcacccttcccaaat 3’); D2Chrn299(forward 5’
accccagactcagcatttga 3’, reverse 5’ tcaaactaccccatcaggattc 3’). DSS, the Dahi sait
sensitive strain. Congenic strains were as follows: DSS.LEW-(D2Ratl99-D2RatÏ43)/Lt
(C2S .L1), DS S .LEW-(D2Rat I 8-D2Chm277)/Lt (C2S .L2), DSS .LEW-(PrÏr
D2Ratl 43)/Lt (C2S .L3) and DSS . LEW-(D2Rat 1 99-D2Mco 1 7)/Lt (C2S .L4) respectively.
MAP refers to the averaged mean arterial pressure during the period of measurernent for
each strain. ANOVA with the Dunnett’s correction compares MAPs between DSS and
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each of the congenic strains. The placement of C2QTL4 is to the right to congenic
strains. Supercontigs were those taken from a database search at
http://www.ncbi.nlm. nih.gov/rnapview/. Numbers in parentheses below supercontigs
represent their sizes in megabases (Mb). Genes found in the QTL-residing region of rat
Chr 2, and homologous regions on mouse ChrI 5 and hurnan CHR 5 are shown to the
right of the rnap, which was based on a database search at
http://www.ncbi.nlrn.nih.gov/mapview/. They are as follows: GdnjÇ guai ccli une derived
neurotrophic factor; IDN3, IDN3 protein; IL7R, interlukin 7 receptor; Kp12, Kp12 protein;
Nup155, nucleoporin l55kDa; SKP2, S phase kinase associated protein 2; and SÏc]a3,
solute carrier farnily I member 3. Locs or FUs refer to possible genes predicted by
computer programs.
Figure 2B. Comparisons of BPs between congenic strains, and the DSS strain. a and
d, systolic arterial pressures (DSAPs), b and e: diastolic arteriai pressures (DAPs), and e
and f, mean arterial pressures (SAPs). Each time point on the graph represents an
average of 6-hour readings. Error bars represent SEM. n refers to thc number of rats.
Lew, the Lewis strain; DSS, Dahi sait-sensitive strain. For designations of congenic
strains, sec the legend for Figure 1.
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Figure 3B. Comparisons of QTLs localized on Clir 2. The rat rnap is synthesized
from several sources including the references cited and http://www-genorne.wi.mit.edu;
http://rgd.rncw.edu; http://www.broad.rnit.edu/resources.htrnl;
http ://www.well .ox . ac.ukkbihoreau/;
http://ratrnap.irns.u-tokyo.ac.jp. Markers in parentheses are adopted from the above
sources. The position of C2QTL4 fine mapped in the current work is as defined by
comparative congenics from Figure 1 and is indicated by a dark bar. Comparisons ofBP
QTL localizations on Chr 2 reported in the literature are shown to the right ofthe rnap.
Shaded bars to the right of the rnap indicate QTL interval estimates, to the best of our
knowledge, for BP QTL regions locaÏized in separate studies specified by reference
numbers situated directly above.
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Chapter $
Discussion
The influence of genetic and environmental factors
8.1 Environmental factors
Every step of our strategy to localise a QTL lias factors that can limit the validity
of the resuits. For example, such factors as age, sex and diet can vary the resuits which
are obtained and make us question the validity of the study and the isolation of the QTL.
These environrnental factors must then be taken into account when considering or
analysing the results.
8.1.1 Sex of the animal
The detection of different QTLs for blood pressure in males and fernales shows us
that there exists certain effects specific to sex and the susceptibility to hypertension.
(74,75) In fernale rats, hypertension appears at a later tirne and progresses at a more
moderate pace than in males. Many female hormones, such as oestrogen, can interfere
with the control of blood pressure. On the other hand, the difference observed in blood
pressure between males and fernales cannot be explained uniquely by hormones and must
imply a completely different group ofregulatory genes.
Most genetic linkage analyses for blood pressure have been done using male rats.
Male rats develop hypertension much more quickly than females and due to their faster
growth, the measure of arterial pressure can be done at a younger age as well. This is why
the majority of studies donc with the goal of isolating the QTLs for arterial blood
pressure have not evaluated the effect of sex on the expression of the QTL5 observed.
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QTLS common to both females and males do exist, but the presence of QTLs
specific to sex creates a need for specific studies with females and the need for specific
female intervention in the human.
8.1.2 Age ofthe animal
Most genetic linkage analysis studies have been done in aduit animais because
arterial pressure augments with age. Development is finished and the phenotype is
expressed entirely only at aduit age. Telemetry analysis is very rigorous when looking at
animal age; starting at ten weeks of age the arterial pressure is evaluated (See figure 11)
8.1.3 Animal diet
The rats which were used in this study have been fed a high sait diet. It lias been
demonstrated that diet can vary arteriai pressure in the S rat (76). SaIt intake is based on
food intake; therefore it is possible that certain rats eat more than others. To counter this
variable effect, the weight of the rats used in telernetry is situated in a precise interval.
(77,78) But, one must note that it is possible that certain rats experience more weight
gain with Ïess food, especiaily the S and congenic strains. It is therefore very important
to consider that hypertension can be related to weight control (79) such as in the
genetically hypertensivc SHR rats (80).
8.1.4 Method of measure of arterial pressure
Three methods are used to measure arterial pressure in the rat: the fastening of the
tau, telernetry and the arterial cathete (81). The method using the tightening of the tau
measures the systolic artenal pressure and implies the mobilisation ofthe extremity ofthe
rat tau. Ail the hypertensive model strains have been seiected using this rncthod,
including the original S rat (82), the R rat as well as the SHR rat. It is a method which is
fast and cost efficient which perrnits to take many measures at a larger scale.
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On thc other hand, the rneasurcs arc indirect, imprecise, last only minutes and do not
detect blood pressure variation under lOmmHg (83).Moreovcr, this rnethod causes stress
to an animal, due to its physical immobilization and this in tum can vary the arterial
pressure. Lastly, it is important to note that it is important to be constant in the
measuring period because arterial pressure can vary from hour to hour.
Telernetry is a method which is reliable and precise. It is direct, continuous and
measures long terni artenal pressure without interruption. The fact that we measure on a
24 h timefrarne penuits us to take into account the diurnal variations of the arterial
pressure. The only downfall is that it is costly and invasive because it requires a surgical
implant.
8.2 Genetic factors
The genetic background composition must be considered as a factor that may
influence blood pressure resuits. The norniotensive strain used in F2 population studies
can have an important effect. For example, a genome scan study using F2 populations
derived from crosses such as S x R, S x BN, S x WKY and S x IVNS detected QTLs on
many chromosomes.($4) Some of these QTLs were observed only in one of the four
crosses, this demonstrates the effect of the genetic background on the expression of the
phenotype. The use ofmany normotensive strains perniits us to introduce various alleles
and genetic backgrounds at the QTL site. On the other hand, the genetic background of a
congenic strain is important to observe the effect of a complex trait.
Another probÏern of the genetic background is the possibility of the presence of
residual loci which onginate from the donor strain. These loci would have gone
unnoticed dunng the verification of the genetic background which is doue using
polymorphie rnarkers which are distributed throughout the genorne. These bd may
interact with the QTL and influence arterial pressure.
7$
8.2.2 The position effect
The flinction of a gene does flot solely depend on the gene itself because it is
influenced by other genes or DNA sequences which are situated close to the gene ($3). A
sequence situated close to a gene can activate or repress the prornoter gene. This
sequence might find itself close to the gene due to a chromosomal rearrangernent during
mitosis or meiosis.
It is important to consider these background effects because they may influence
resuits. In the long run, it is difficult to determine if an effect on arterial pressure is due to
a substituted chrornosornal fragment in a congenic strain or simply due to a difftised
genetic background effect. The strategy used to evaluate if a position effect is responsible
for arterial pressure variation is to construct a congenic strain which possesses a
substituted chrornosomal fragment right next to, but without overlapping, the previous
strain ($4).
8.2.3 Interaction between the QTLs
Presently many blood pressure QTL5 have bcen localised using S rats ($5). An
interesting aspect that emerges from these studies is that it is possible to consider blood
pressure, a polygenic trait, and to fraction it into multiple monogenic traits. In other
words, every blood pressure QTL could function as a unique genetic unit independent of
other QTLs in an appropriate genetic background.
Genetic linkage analysis studies dernonstrate the presence of a QTL is most often
in very large chromosomal fragments. With the help of congenics, it is possible to
detenuine how many QTLs are situated in a candidate region as well as evaluating their
individual and cornbined effect on blood pressure. For example, on chromosome 10 of
the S rat, it was determined that a chromosomal fragment which was found by genetic
linkage analysis contained 3 isolated QTLs which acted in an additive fashion ($6).
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Another example would be chromosome 3 where an epistasis lias been
demonstrated to occur. Two QTLs which have an opposite effect on blood pressure have
been localised on clirornomose 3 using rnany congenic strains. When these 2 QTL5 are
present in the same congenic strain, the effect of the blood pressure augmenting QTL is
rnasked by that of the blood pressure lowering QTL (87). The fact that LEW contains
alleles that can increase blood pressure is surprising. Sirnilar resuits have also been found
on chromosome 8 as well as in this study on chromosome 2. These resuits demonstrate
that to be normotensive, a strain such as LEW is flot obliged to be carrying blood
pressure lowering alleles in every one of it’s QTL5. Therefore, the determination ofblood
pressure in rats would be the resuit of a refined structure of QTLs, sornetimes possessing
contrary effects, and would form a genetic organisation which could be applied to other
mammals such as the human.
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Chr Contrasting Number of Confirmed by congenic Details
strains QTLs strains
1 LEW 3 Yes
2 WKY 3 Yes Interaction with QTLs of Chr.10 (62)
MNS 3 Yes
LEW 1 Yes
3 R 1 Yes
LEW 2 Yes 2 QTLs=epistasis (87)
5 LEW 2 Yes
7 R 1 Yes
8 LEW 2 Yes Two QTLs with opposing effcets on blood
pressure (71)
9 R 1 Yes
10 MNS 2 Yes
LEW 3 Yes Three additive QTLs (59)
12 WKY 1 No
13 R 1 Yes
BN 1 Yes
15 WKY 1 No
16 LEW 1 Yes
BN 1 Yes
17 LEW 1 Yes
18 LEW 2 Yes
BN 1 Yes
Table IV- BP QTLs localized in the Dahl sait-sensitive rat
Adapted from Deng A.Y (55). The contrasting strain is the normotensive rat strain implied in localizing the QTL on the
chromosome. Chr, chromosome; S, Dahi sait-sensitive; LEW, Lewis; WKY, Wistar-Kyoto; MNS, Milan
nol700tensive; R, Dahl sait-resistant; BN. Brown-Norway.
At first glance once can assume that the effects of multiple QTLs are additive. But
in a complex disease such as hypertension, there exist epistatic interactions between
QTLs (88). An epistasis is a dominance of one gene over another. This interaction is
inevitable when we observe the number of different blood pressure QTLs which have
been isolated throughout the genome and their drastic effect when evaluated separately.
Therefore, these QTLs interact amongst themselves and do not all equally contribute to
the overali blood pressure, this means the effect of one QTL can mask that of another
($9).
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Chapter 9
Discussion of present work
Hypertension is a complex disease where many environmental and genetic factors
contribute to a variation in blood pressure. There are two forms of this disease: essential
and monogenic. The identification of causative genes involved in hypertension will
permit a better comprehension of the pathophysiology of the disease as well as a better
treatrnent. However, the essential forrn is multigenic, this renders its genetic dissection
quite difficuit. Using animal models facilitates this task.
It was previously suggested that the region between D2rat 18 and Prir markers on
chromosome 2 is linked to essential hypertension. We wanted to verify this hypothesis by
determining the presence of a QTL in this region. By developing a detailed chrornosomal
rnap we were able to construct congenic strains using the rat as a model. This penriitted
us to demonstrate that the considered region lias a significant impact on arterial pressure
caused by a blood pressure raising QTL.
There are many findings in this work, but the essential ones to be retained are the
following four. The first is that LEW as well as Dahl Sait-Sensitive can carry blood
pressure raising alleles even thouglit this strain is thought to be nonnotensive and not
hypertensive. This fact indicates that it is not a single QTL, but rather it is how this QTL
interacts with others, that determine the overali BP of a strain. Among the rnechanisms
of interactions, one can be epistasis.
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Also, in the current work we have succeeded in reducing the area of interest of the
QTL to an interval of around 3 cM, we were able to accomplish this through much
breeding and by using comparative genomics. By comparing the two strains that had no
blood pressure effect with those that did we were able to determine that this region
contained 19 possible genes, 4 known and 15 undefined Locs (Table V).
Name L HomoloqK Alias
L0C365692 similar to 40S ribosomal protein S9
L0C365693 similar to hypothetical protein
guai ccli une derived neurotrophic H: GDNF M:
Gdnf factor Gdnf
L0C294783
LOC3 10136 moved to ChrS
H: NUP155
NuplSS nucleoporin 155 M:Nup155
predicted similar to hypothetical H:fL113231
LOC3 10327 protein FLJ 13231 (predicted) M: 241 0089E03 RGD 131 00$ 1
LOC3 65494
L0C2947$7
L0C365697 similar to ribosomal protein 512
FLC 1 $3 no longer exists
L0C365698
L0C2947$$
predicted similar to S-phase
kinase-associated protein 2 (F-box
protein Skp2) (F-box/WD-40
L0C294790 protein 1) (predicted) RGD1562456
H:UGT3A2 M:Ugt3aI
and Ugt3a2 (UDP
predicted similar to Hypothetical glycosyltransferase 3
family polypeptide A”
L0C294793 protein MGC37820 (predicted) or AI)’ - RGD 1564365
predicted calcyphosine-like H: CAPSL Capsi;
L0C294795 (predicted) M:Capsl RGD 1308776
L0C294797
KP12 no longer exists
Table V- Table of genes and Locs in QTL region
Includes their homology in the human and rat as weIl as their alias
C)
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0f the 19 genes included in thc QTL region, 7 Locs have no defined functions
which have been discovered as of yet. This leads us to believe that the nove! gene which
would influence blood pressure would be one ofthese because the other Locs which have
defined functions are not thought to be linked to hypertension. The other four known
genes are also flot thought to be linked to hypertension and with the updated version of
the genetic sequences two of the four genes do flot even exist in this region anyrnore. 0f
the two genes that stil! exist, Gdnf is known to be essential to brain function and the
second Nup155 is important to the pores ofcellular membranes.
In this study we have confirrned the presence of a QTL but at the sarne time
Agtr]b (Angiotensin Receptor lB), which has been thought to be a candidate gene in the
past has been disqualified because C2S.L3 had a BP not distinguishable from that ofDahl
Sait-Sensitive. Besides Agtrlb there seem to be no apparent genes which are ofinterest at
the moment but with flirther studies and more precise QTL mapping it will lead to the
identification of a nove! gene previous!y unknown to influence BP.
In future studies, in order for one to truly prove that this region does indeed
contain a blood pressure QTL, we must make a congenic strain that specifically contains
the interval of D2Chml45 and Prir. This small strain which should measure at the most
1cM wou!d be idea! flot onÏy for confirmation of this QTL but a!so for final molecular
identification. Another advantage a sma!!er and more specific congenic strain would
bring is finding out whether or flot the fragment between D2Chrn277 and Prtr contains
one or two QTLs. We must rernember that the possibility of there being two QTLs in this
region cannot be excluded.
We also concluded that for the moment Agtr]b is not supported as a candidate
gene for the QTL because congenic strain C2S.L3 harbors it, and yet, did not show a BP
effect (Figures 1 and 2 in artic!e). Using homology mapping with the rat, mouse and
hurnan genornes, we found no obvious candidate genes which have been known to
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influence blood pressure or hypertension in the region containing the QTL. Thus, it is
most Jikely that this QTL will represent a novel gene for BP regulation.
C2QTL4 identified in our current work seerns to be unique in its chromosome
location and, in contrast to other BP QTLs, in its BP-increasing effect from Dahi Sait
Sensitive. These effects have to be further studied in order to narrow and target the region
further in order to find a candidate gene and to establish a mechanisrn by which this QTL
interacts with others.
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Chapter 10
Conclusion and Perspectives
A large part of rny work in the laboratory consisted in generating a genetic rnap
rich and dense in markers for chromosome 2. This was accomplished by integrating the
rnaps available on the internet, by constructing new markers fiom the genornic sequence
which is presently available and by positioning them on congenic strains.
A good genetic rnap permits a better characterization of the congenic strains and
substrains. This in turn perrnits a better detection of possible cross-overs during breeding.
The rats presenting these interesting traits are used to develop congenic sub-strains. This
step is crucially important when the QTL regions are small.
Another part of my work consisted of genotyping rats each week. The genotyping
was done with PCR by using different polymorphie rnarkers and positioning them on
rnaps. The genotyping of rats is very important and demands rnuch precision.
Given the number of candidate genes in every QTL region, the next step would be
to reduce these QTL regions. This can be accornplished with the construction of new
congenic sub-strains. Telemetry will then be used to identify the positive and negativc
strains therefore reducing the QTL region. Once the region is reduced to 1 cM
comparative sequencing can then begin searching for mutations.
The application of computer and internet tools which are available have played a
big role in this project. With the advancement of technology as weIl as that availability of
the genomic sequence more and more tools are at hand. One can only wonder what the
future holds for a science which is ever evolving.
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